Please ensure Javascript is enabled for purposes of website accessibility

Here's Why Neptune Technologies & Bioressources Inc. Rose as Much as 14% Today

By Maxx Chatsko - Feb 12, 2018 at 4:24PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The tiny marijuana stock announced a new partnership.

What happened

Shares of wellness products specialist Neptune Technologies & Bioressources (NEPT -4.76%) rose as much as 14% Monday after the company announced a new partnership with Tetra Bio Pharma. The pair will collaborate to develop, commercialize, and market purified cannabinoid oil products for the treatment of pain and inflammation. Products will also be sold in veterinary markets.

Both Canadian companies have repositioned themselves with a focus on cannabis products in recent years, and risen from penny stocks to companies with $100 million-plus market caps in the process. As of 3:43 p.m. EST Monday, the stock had settled to a 13.7% gain.

A person in a shirt and tie drawing a green chart showing growth on the screen.

Image source: Getty Images.

So what

The fact that both Neptune Technologies and Tetra Bio Pharma are based in Canada has no doubt aided the share prices of the companies. Canada is nearing the opening of a retail cannabis market following a series of deregulatory actions. Meanwhile, both Canada and the United States allow at least a few specific uses of cannabis-based products for veterinary applications.

That said, investors should not overlook the fact that the businesses have much to prove. Neptune Technologies reported just $6.7 million in revenue in the most recent quarter and continues to record losses. The business does report healthy profit margins near 20%, but it remains a long way from cash-flow-neutral or profitable operations.

Now what

Marijuana stocks have been on fire in the last year or so following several sweeping changes to the regulation of cannabis products in North America. While that could create newfound opportunities for companies, investors should stick to traditional financial analysis when evaluating potential investments. Monday's announcement could be a step in the right direction for Neptune Technologies, but the company is a drop in the bucket and quarters away from producing results. Just something to keep in mind.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Neptune Wellness Solutions Inc. Stock Quote
Neptune Wellness Solutions Inc.
NEPT
$1.40 (-4.76%) $0.07

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
317%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.